Z-2887-2026 Class II Ongoing
FDA device recall Z-2887-2026 was initiated by Hardy Diagnostics on Jun 8, 2026 and is designated Class II. Reason for recall: Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective… The recall status is ongoing. Affected quantity: 43 units.
Recall details
- Product Type
- Devices
- Report Date
- Aug 12, 2026
- Initiation Date
- Jun 8, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 43 units
Product description
HardyDisk AST Cefiderocol 30¿g (FDC30) REF Z9435 HardyDisk AST Cefiderocol 30¿g (FDC30) for in vitro agar diffusion susceptibility testing is indicated when there is the need to determine the susceptibility of Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii complex and Stenotrophomonas maltophilia to Cefiderocol,
Reason for recall
Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective antimicrobial therapy, potentially resulting in delayed appropriate treatment, prolonged infection, or worsening clinical outcome.
Distribution pattern
U.S. Nationwide distribution in the states of AZ, CA, FL, ID, IN, MA, MS, NJ, NV, NY, OH, PA, and TN.
Code information
Catalog Number: Z9435 UD-DI code: Pending Lot Number: 543461
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2887-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026